微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 78.81% | 0.73% | 3.42% | 6/141 | 52.4% | 佰仁医疗科技 | 88.71% | 行业排名> |
| 2026-03-31 | 76.21% | -0.62% | -2.35% | 11/141 | 52.37% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-12-31 | 78.04% | -1.82% | 0.37% | 9/141 | 51.9% | 佰仁医疗科技 | 89.18% | 行业排名> |
| 2025-09-30 | 77.75% | -3.28% | -0.62% | 9/141 | 52.23% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-06-30 | 78.24% | -3.48% | 2.03% | 9/141 | 52.48% | 佰仁医疗科技 | 88.54% | 行业排名> |
| 2025-03-31 | 76.68% | -4.81% | -3.53% | 14/141 | 52.13% | 佰仁医疗科技 | 85.72% | 行业排名> |
| 2024-12-31 | 79.49% | -2.18% | -1.12% | 7/141 | 53.08% | 佰仁医疗科技 | 88.34% | 行业排名> |
| 2024-09-30 | 80.39% | -1.62% | -0.82% | 6/141 | 53.87% | 佰仁医疗科技 | 88.56% | 行业排名> |
| 2024-06-30 | 81.05% | -0.49% | 0.62% | 5/141 | 53.95% | 佰仁医疗科技 | 89.27% | 行业排名> |
| 2024-03-31 | 80.56% | 0.17% | -0.86% | 8/141 | 53.88% | 佰仁医疗科技 | 89.28% | 行业排名> |
| 2023-12-31 | 81.26% | 24% | -0.56% | 7/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 81.72% | 17.62% | 0.32% | 6/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 81.46% | 19.7% | 1.28% | 8/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 80.42% | 16.32% | 22.73% | 10/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 65.53% | -12.19% | -5.68% | 41/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 69.48% | 2% | 2.09% | 31/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 68.05% | -11.19% | -1.58% | 35/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 69.14% | 2% | -7.35% | 34/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 74.62% | -1.65% | -2.61% | 23/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 76.63% | 2% | 0.99% | 19/141 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 75.87% | -14.63% | -14.63% | 28/141 | 60.12% | 正海生物 | 90.78% | 行业排名> |
| 2019-12-31 | 88.87% | 0.78% | 0.78% | 5/141 | 56.96% | 正海生物 | 91.59% | 行业排名> |
| 2018-12-31 | 88.18% | 2% | 2% | 5/141 | 56.22% | 正海生物 | 92.23% | 行业排名> |